XML 58 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Details) - Schedule of Number of Common Shares Issuable Upon Conversion or Exercise - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 14,028,557 13,152,568
Series 1 Convertible Preferred Stock [Member]    
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 225,231 225,231
Series 2 Convertible Preferred Stock [Member]    
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 5,845,695 5,845,695
Series 2 Convertible Preferred Stock Issuable Upon Exercise of Warrants [Member]    
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 116,903
Common Stock Options [Member]    
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 4,452,447 3,919,228
Common Stock Warrants [Member]    
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 2,255,184 2,255,184
Performance Share Units [Member]    
Schedule of Number of Common Shares Issuable Upon Conversion or Exercise [Line Items]    
Antidilutive securities excluded from computation of earnings per share 1,250,000 790,327